METAGENOMI THERAPEUTICS INC (MGX) Stock Balance Sheet
NASDAQ:MGX • US59102M1045
Current stock price
1.44 USD
0 (0%)
At close:
1.44 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 41.72M | 27.39M | 140.60M | 184.44M | 39.30M | |||
| Marketable Securities | 119.08M | 220.92M | 130.58M | 177.69M | 68.86M | |||
| Receivables | 305.00K | 1.26M | 2.45M | 1.95M | 490.00K | |||
| Other Current Assets | 4.43M | 8.40M | 4.64M | 2.82M | 272.00K | |||
| Total Current Assets | 165.54M | 257.96M | 278.27M | 366.90M | 108.92M | |||
| Non-Current Assets | ||||||||
| PPE Net | 47.38M | 57.66M | 65.15M | 33.26M | 21.89M | |||
| Investments And Advances | 2.15M | 3.45M | 10.68M | 7.81M | 6.42M | |||
| Other Non-Current Assets | 6.03M | 5.54M | 10.74M | 6.52M | 4.77M | |||
| Total Non-Current Assets | 55.56M | 66.64M | 86.57M | 47.59M | 33.08M | |||
| TOTAL ASSETS | 221.10M | 324.60M | 364.84M | 414.49M | 141.99M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 12.74M | 14.01M | 14.90M | 10.30M | 4.22M | |||
| Accounts Payable | 1.49M | 533.00K | 1.79M | 2.01M | 1.35M | |||
| Other Current Liabilities | 8.70M | 22.76M | 52.17M | 36.22M | 19.60M | |||
| Total Current Liabilities | 22.93M | 37.31M | 68.86M | 48.54M | 25.17M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 30.28M | |||
| Other Non-Current Liabilities | 39.57M | 52.43M | 80.81M | 94.27M | 42.59M | |||
| Total Non-Current Liabilities | 39.57M | 52.43M | 80.81M | 94.27M | 72.87M | |||
| TOTAL LIABILITIES | 62.51M | 89.74M | 149.67M | 142.81M | 98.04M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -310.87M | -223.00M | -135.51M | -74.18M | -32.55M | |||
| Additional Paid In Capital | 469.20M | 457.15M | N/A | N/A | N/A | |||
| Common Shares | 4.00K | 4.00K | 350.78M | 346.13M | 76.52M | |||
| Other Shareholders' Equity | 260.00K | 709.00K | -97.00K | -274.00K | -21.00K | |||
| Shares Outstanding | 37.62M | 37.42M | 37.53M | 37.53M | 37.53M | |||
| Tangible Book Value per Share | 4.22 | 6.28 | -3.61 | -1.98 | -0.87 | |||
| Total Shareholders' Equity | 158.60M | 234.86M | 215.17M | 271.68M | 43.95M | |||
| TOTAL LIABILITIES AND EQUITY | 221.10M | 324.60M | 364.84M | 414.49M | 141.99M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.69 | |||
| Current Ratio | 7.22 | 6.91 | 4.04 | 7.56 | 4.33 | |||
| Return On Assets (ROA) | -39.74% | -24.05% | -18.71% | -10.52% | -15.10% | |||
| Return On Equity (ROE) | -55.40% | -33.24% | -31.72% | -16.05% | -48.79% | |||
All data in USD , ROIC based on taxRate of 0.21